These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 34354889)

  • 1. Coronavirus Disease-Associated Mucormycosis from a Tertiary Care Hospital in India: A Case Series.
    Singh Y; Ganesh V; Kumar S; Patel N; Aggarwala R; Soni KD; Trikha A
    Cureus; 2021 Jul; 13(7):e16152. PubMed ID: 34354889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
    Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
    Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucormycosis an added burden to Covid-19 Patients: An in-depth systematic review.
    Shah NN; Khan Z; Ahad H; Elderdery AY; Alomary MN; Atwah B; Alhindi Z; Alsugoor MH; Elkhalifa AME; Nabi S; Bashir SM; Yaqub T; Rather GA; Ansari MA
    J Infect Public Health; 2022 Nov; 15(11):1299-1314. PubMed ID: 36279686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19-Associated mucormycosis: Case series from a tertiary care hospital in South India.
    Rashbi K S; Ali TMF; P N D; C K S; Payyappilly RJ
    Access Microbiol; 2022 Aug; 4(6):acmi000360. PubMed ID: 36004359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for COVID-19 associated mucormycosis in India: A case control study.
    Patel AK; Bakshi H; Shah K; Patel S; Patel T; Patel K; Patel KK
    Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35709394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 and mucormycosis superinfection: the perfect storm.
    Al-Tawfiq JA; Alhumaid S; Alshukairi AN; Temsah MH; Barry M; Al Mutair A; Rabaan AA; Al-Omari A; Tirupathi R; AlQahtani M; AlBahrani S; Dhama K
    Infection; 2021 Oct; 49(5):833-853. PubMed ID: 34302291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 associated multisystemic mucormycosis from India: a multicentric retrospective study on clinical profile, predisposing factors, cumulative mortality and factors affecting outcome.
    Sahu M; Shah M; Mallela VR; Kola VR; Boorugu HK; Punjani AAR; Kumar RV; Kumar S; Manusrut M; Kumar SCR; Rathod R; Babu DM; Gonuguntla HK; Yedlapati GK; Mallu GR; Reddy YS; Reddy VV; Alwala S; Bongu VK; Kamalesh A; Kumar RNK; Jaishetwar GS; Bagapally RS; Srinivas JS; Balasubramaniam A; Rajagopalan BK; Pullikanti B; Prakasham SP; Nimmala P; Nagaraju B; Sahoo PR;
    Infection; 2023 Apr; 51(2):407-416. PubMed ID: 35922704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Associated Mucormycosis.
    Tazeem S; Nagaraju A; Begum H; Tommi JA; Sudarshan Reddy L; Vijay Kumar M
    Indian J Otolaryngol Head Neck Surg; 2023 Jun; 75(4):1-9. PubMed ID: 37362123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes, COVID 19 and mucormycosis: Clinical spectrum and outcome in a tertiary care medical center in Western India.
    Mishra Y; Prashar M; Sharma D; Akash ; Kumar VP; Tilak TVSVGK
    Diabetes Metab Syndr; 2021; 15(4):102196. PubMed ID: 34246939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
    Rao C; R M
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhinocerebral Mucormycosis: An Emerging Threat in the Era of COVID-19.
    Maassarani D; Bassil GF; Nehme M; Nassar A; Ghanime G; Sleiman Z
    Cureus; 2022 Aug; 14(8):e28057. PubMed ID: 36127989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Second COVID-19 Wave Is a Tsunami With Aftershocks: Mucormycosis Ire as Seen in a Tertiary Care Hospital in Uttarakhand, India.
    Raina D; Rohilla R; Patwal S; Pandita A
    Cureus; 2023 Oct; 15(10):e47358. PubMed ID: 38021725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Retrospective Analysis of Risk Factors of COVID-19 Associated Mucormycosis and Mortality Predictors: A Single-Center Study.
    Zirpe K; Pote P; Deshmukh A; Gurav SK; Tiwari AM; Suryawanshi P
    Cureus; 2021 Oct; 13(10):e18718. PubMed ID: 34790473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological association of mucormycosis in COVID 19 pandemic.
    Varshney M; Saxena A; Binnani N; Kumar V; Vyas SP
    Indian J Pathol Microbiol; 2023; 66(1):101-105. PubMed ID: 36656219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New-onset hyperglycaemia and prolonged systemic corticosteroids therapy in mild COVID-19 patients as major risk factors for invasive mucormycosis: a preliminary study.
    Khichar S; Samantaray S; Kumar D; Mobarsa V; Jain V; Sharma V; Soni K; Choudhury B; Goyal A; Shankar Meena D; Srinivasan S; Dutt N; Bhardwaj P; Agarwal A; Kumar Garg M; Misra S
    Curr Med Mycol; 2021 Sep; 7(3):22-28. PubMed ID: 35528622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of Case of Mucormycosis (March 2020-May 2021) under strict protocol driven management care in a COVID-19 specific tertiary care intensive care unit.
    Mulakavalupil B; Vaity C; Joshi S; Misra A; Pandit RA
    Diabetes Metab Syndr; 2021; 15(4):102169. PubMed ID: 34198110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [COVID-19 associated mucormycosis. A case in Argentina].
    Aparicio M; Tuculet B; Rivolier MG; Forte A; Vila A
    Medicina (B Aires); 2022; 82(2):304-307. PubMed ID: 35417397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological Study of Mucormycosis in COVID-19 Patients: Experience From a Tertiary Care Center in South India.
    Kandasamy S; Muthuraju S; Vasugi A; Chandrasekar M; Murugan R; Inbasekaran P; R P
    Cureus; 2022 Mar; 14(3):e23016. PubMed ID: 35419223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach.
    Azhar A; Khan WH; Khan PA; Alhosaini K; Owais M; Ahmad A
    J Infect Public Health; 2022 Apr; 15(4):466-479. PubMed ID: 35216920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights from Surgically treated Post Covid Acute Invasive Fungal Rhino-Orbital sinusitis in Chandrapur Study (SPAROS): A Population Based study of Coronavirus Associated Mucormycosis (CAM) characteristics in India.
    Kasatwar A; Shukla R; Rathod N; Nandanwar J; Mishra D; Dhobley A
    IJID Reg; 2022 Dec; 5():21-29. PubMed ID: 36035237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.